UniProt ID | MD1L1_HUMAN | |
---|---|---|
UniProt AC | Q9Y6D9 | |
Protein Name | Mitotic spindle assembly checkpoint protein MAD1 | |
Gene Name | MAD1L1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 718 | |
Subcellular Localization | Nucleus. Chromosome, centromere, kinetochore . Nucleus envelope . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, spindle. Cytoplasm, cytoskeleton, spindle pole . Detected at the nucleus envelope during in | |
Protein Description | Component of the spindle-assembly checkpoint that prevents the onset of anaphase until all chromosomes are properly aligned at the metaphase plate. May recruit MAD2L1 to unattached kinetochores. Has a role in the correct positioning of the septum. Required for anchoring MAD2L1 to the nuclear periphery. Binds to the TERT promoter and represses telomerase expression, possibly by interfering with MYC binding.. | |
Protein Sequence | MEDLGENTMVLSTLRSLNNFISQRVEGGSGLDISTSAPGSLQMQYQQSMQLEERAEQIRSKSHLIQVEREKMQMELSHKRARVELERAASTSARNYEREVDRNQELLTRIRQLQEREAGAEEKMQEQLERNRQCQQNLDAASKRLREKEDSLAQAGETINALKGRISELQWSVMDQEMRVKRLESEKQELQEQLDLQHKKCQEANQKIQELQASQEARADHEQQIKDLEQKLSLQEQDAAIVKNMKSELVRLPRLERELKQLREESAHLREMRETNGLLQEELEGLQRKLGRQEKMQETLVGLELENERLLAKLQSWERLDQTMGLSIRTPEDLSRFVVELQQRELALKDKNSAVTSSARGLEKARQQLQEELRQVSGQLLEERKKRETHEALARRLQKRVLLLTKERDGMRAILGSYDSELTPAEYSPQLTRRMREAEDMVQKVHSHSAEMEAQLSQALEELGGQKQRADMLEMELKMLKSQSSSAEQSFLFSREEADTLRLKVEELEGERSRLEEEKRMLEAQLERRALQGDYDQSRTKVLHMSLNPTSVARQRLREDHSQLQAECERLRGLLRAMERGGTVPADLEAAAASLPSSKEVAELKKQVESAELKNQRLKEVFQTKIQEFRKACYTLTGYQIDITTENQYRLTSLYAEHPGDCLIFKATSPSGSKMQLLETEFSHTVGELIEVHLRRQDSIPAFLSSLTLELFSRQTVA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MEDLGENT -------CCCCHHHH | 9.02 | 22223895 | |
8 | Phosphorylation | MEDLGENTMVLSTLR CCCCHHHHHHHHHHH | 12.35 | 20068231 | |
12 | Phosphorylation | GENTMVLSTLRSLNN HHHHHHHHHHHHHHH | 17.62 | 22199227 | |
13 | Phosphorylation | ENTMVLSTLRSLNNF HHHHHHHHHHHHHHH | 23.25 | 22199227 | |
16 | Phosphorylation | MVLSTLRSLNNFISQ HHHHHHHHHHHHHHH | 38.26 | 25159151 | |
22 | Phosphorylation | RSLNNFISQRVEGGS HHHHHHHHHCCCCCC | 14.06 | 24043423 | |
29 | Phosphorylation | SQRVEGGSGLDISTS HHCCCCCCCCCCCCC | 47.22 | 18922800 | |
55 | Ubiquitination | SMQLEERAEQIRSKS HHHHHHHHHHHHCCH | 19.14 | 29967540 | |
61 | Acetylation | RAEQIRSKSHLIQVE HHHHHHCCHHHHHHH | 31.85 | 19608861 | |
61 | Sumoylation | RAEQIRSKSHLIQVE HHHHHHCCHHHHHHH | 31.85 | - | |
61 | Ubiquitination | RAEQIRSKSHLIQVE HHHHHHCCHHHHHHH | 31.85 | 19608861 | |
61 | Sumoylation | RAEQIRSKSHLIQVE HHHHHHCCHHHHHHH | 31.85 | 28112733 | |
62 | Phosphorylation | AEQIRSKSHLIQVER HHHHHCCHHHHHHHH | 25.44 | 28555341 | |
68 | Ubiquitination | KSHLIQVEREKMQME CHHHHHHHHHHHHHH | 38.45 | 23000965 | |
70 | Ubiquitination | HLIQVEREKMQMELS HHHHHHHHHHHHHHH | 39.10 | 29967540 | |
71 | Ubiquitination | LIQVEREKMQMELSH HHHHHHHHHHHHHHH | 40.42 | 23000965 | |
75 | Ubiquitination | EREKMQMELSHKRAR HHHHHHHHHHHHHHH | 30.17 | 29967540 | |
76 | Ubiquitination | REKMQMELSHKRARV HHHHHHHHHHHHHHH | 5.65 | 24816145 | |
77 | Phosphorylation | EKMQMELSHKRARVE HHHHHHHHHHHHHHH | 17.41 | 25159151 | |
79 | Ubiquitination | MQMELSHKRARVELE HHHHHHHHHHHHHHH | 44.36 | 29967540 | |
79 | 2-Hydroxyisobutyrylation | MQMELSHKRARVELE HHHHHHHHHHHHHHH | 44.36 | - | |
81 | Ubiquitination | MELSHKRARVELERA HHHHHHHHHHHHHHH | 25.36 | 21890473 | |
90 | Phosphorylation | VELERAASTSARNYE HHHHHHHHHCCHHHH | 23.16 | 22067460 | |
91 | Phosphorylation | ELERAASTSARNYER HHHHHHHHCCHHHHH | 22.98 | 22461510 | |
92 | Phosphorylation | LERAASTSARNYERE HHHHHHHCCHHHHHH | 23.80 | 22067460 | |
94 | Ubiquitination | RAASTSARNYEREVD HHHHHCCHHHHHHHH | 46.13 | 24816145 | |
96 | Phosphorylation | ASTSARNYEREVDRN HHHCCHHHHHHHHHH | 15.71 | 22461510 | |
115 | Ubiquitination | TRIRQLQEREAGAEE HHHHHHHHHHHCHHH | 62.17 | 29967540 | |
123 | Ubiquitination | REAGAEEKMQEQLER HHHCHHHHHHHHHHH | 37.07 | 24816145 | |
139 | Ubiquitination | RQCQQNLDAASKRLR HHHHHHHHHHHHHHH | 47.87 | 29967540 | |
142 | Phosphorylation | QQNLDAASKRLREKE HHHHHHHHHHHHHHH | 21.74 | 24260401 | |
143 | Acetylation | QNLDAASKRLREKED HHHHHHHHHHHHHHH | 51.21 | 25953088 | |
143 | Ubiquitination | QNLDAASKRLREKED HHHHHHHHHHHHHHH | 51.21 | 29967540 | |
143 | 2-Hydroxyisobutyrylation | QNLDAASKRLREKED HHHHHHHHHHHHHHH | 51.21 | - | |
148 | Ubiquitination | ASKRLREKEDSLAQA HHHHHHHHHHHHHHH | 61.46 | 29967540 | |
156 | Ubiquitination | EDSLAQAGETINALK HHHHHHHHHHHHHHH | 22.09 | 23000965 | |
159 | Ubiquitination | LAQAGETINALKGRI HHHHHHHHHHHHHHH | 2.18 | 23000965 | |
163 | Ubiquitination | GETINALKGRISELQ HHHHHHHHHHHHHHH | 43.67 | 29967540 | |
172 | Phosphorylation | RISELQWSVMDQEMR HHHHHHHHHHCHHHH | 8.46 | 26074081 | |
182 | Ubiquitination | DQEMRVKRLESEKQE CHHHHHHHHHHHHHH | 40.61 | 24816145 | |
185 | Phosphorylation | MRVKRLESEKQELQE HHHHHHHHHHHHHHH | 55.47 | 26074081 | |
187 | Ubiquitination | VKRLESEKQELQEQL HHHHHHHHHHHHHHH | 59.35 | 24816145 | |
207 | Ubiquitination | KCQEANQKIQELQAS HHHHHHHHHHHHHHH | 46.28 | 29967540 | |
214 | Phosphorylation | KIQELQASQEARADH HHHHHHHHHHHHHHH | 18.65 | 17525332 | |
215 | Ubiquitination | IQELQASQEARADHE HHHHHHHHHHHHHHH | 51.92 | 21890473 | |
221 | Ubiquitination | SQEARADHEQQIKDL HHHHHHHHHHHHHHH | 33.51 | 29967540 | |
221 | Ubiquitination | SQEARADHEQQIKDL HHHHHHHHHHHHHHH | 33.51 | - | |
231 | Ubiquitination | QIKDLEQKLSLQEQD HHHHHHHHHCHHHHH | 30.57 | 29967540 | |
233 | Phosphorylation | KDLEQKLSLQEQDAA HHHHHHHCHHHHHHH | 34.73 | 28555341 | |
259 | Ubiquitination | LPRLERELKQLREES HHHHHHHHHHHHHHH | 5.54 | 24816145 | |
266 | Phosphorylation | LKQLREESAHLREMR HHHHHHHHHHHHHHH | 19.08 | 27174698 | |
303 | Ubiquitination | MQETLVGLELENERL HHHHHHCHHHHCHHH | 5.46 | 21890473 | |
304 | Ubiquitination | QETLVGLELENERLL HHHHHCHHHHCHHHH | 48.38 | 24816145 | |
313 | Ubiquitination | ENERLLAKLQSWERL HCHHHHHHHHHHHHH | 47.21 | 29967540 | |
314 | Ubiquitination | NERLLAKLQSWERLD CHHHHHHHHHHHHHH | 3.97 | 23000965 | |
323 | Phosphorylation | SWERLDQTMGLSIRT HHHHHHHHCCCCCCC | 16.93 | 20068231 | |
324 | Sulfoxidation | WERLDQTMGLSIRTP HHHHHHHCCCCCCCH | 4.17 | 21406390 | |
327 | Phosphorylation | LDQTMGLSIRTPEDL HHHHCCCCCCCHHHH | 12.32 | 20068231 | |
336 | Phosphorylation | RTPEDLSRFVVELQQ CCHHHHHHHHHHHHH | 35.36 | 32142685 | |
351 | Ubiquitination | RELALKDKNSAVTSS HHHHHCCCCCHHHHH | 51.74 | 24816145 | |
358 | Phosphorylation | KNSAVTSSARGLEKA CCCHHHHHHHHHHHH | 16.78 | 26546556 | |
359 | Ubiquitination | NSAVTSSARGLEKAR CCHHHHHHHHHHHHH | 14.88 | 23000965 | |
375 | Ubiquitination | QLQEELRQVSGQLLE HHHHHHHHHHHHHHH | 46.48 | 29967540 | |
377 | Phosphorylation | QEELRQVSGQLLEER HHHHHHHHHHHHHHH | 16.69 | - | |
386 | Ubiquitination | QLLEERKKRETHEAL HHHHHHHHHHHHHHH | 62.78 | 23000965 | |
389 | Ubiquitination | EERKKRETHEALARR HHHHHHHHHHHHHHH | 29.11 | 23000965 | |
389 | Ubiquitination | EERKKRETHEALARR HHHHHHHHHHHHHHH | 29.11 | - | |
406 | Ubiquitination | KRVLLLTKERDGMRA HHHHHHCCCCCCHHH | 51.20 | 23000965 | |
406 | 2-Hydroxyisobutyrylation | KRVLLLTKERDGMRA HHHHHHCCCCCCHHH | 51.20 | - | |
412 | Ubiquitination | TKERDGMRAILGSYD CCCCCCHHHHHCCCC | 24.81 | 24816145 | |
412 | Ubiquitination | TKERDGMRAILGSYD CCCCCCHHHHHCCCC | 24.81 | - | |
415 | Ubiquitination | RDGMRAILGSYDSEL CCCHHHHHCCCCCCC | 3.49 | 24816145 | |
417 | Phosphorylation | GMRAILGSYDSELTP CHHHHHCCCCCCCCH | 23.48 | 23403867 | |
418 | Phosphorylation | MRAILGSYDSELTPA HHHHHCCCCCCCCHH | 22.99 | 30266825 | |
420 | Phosphorylation | AILGSYDSELTPAEY HHHCCCCCCCCHHHC | 26.69 | 30266825 | |
423 | Phosphorylation | GSYDSELTPAEYSPQ CCCCCCCCHHHCCHH | 19.19 | 30266825 | |
427 | Phosphorylation | SELTPAEYSPQLTRR CCCCHHHCCHHHHHH | 27.97 | 30266825 | |
428 | Phosphorylation | ELTPAEYSPQLTRRM CCCHHHCCHHHHHHH | 9.55 | 25159151 | |
431 | Ubiquitination | PAEYSPQLTRRMREA HHHCCHHHHHHHHHH | 4.58 | 23000965 | |
432 | Phosphorylation | AEYSPQLTRRMREAE HHCCHHHHHHHHHHH | 15.81 | 30266825 | |
434 | Ubiquitination | YSPQLTRRMREAEDM CCHHHHHHHHHHHHH | 24.23 | 23000965 | |
447 | Phosphorylation | DMVQKVHSHSAEMEA HHHHHHHHCHHHHHH | 23.33 | 23401153 | |
449 | Phosphorylation | VQKVHSHSAEMEAQL HHHHHHCHHHHHHHH | 29.01 | 23532336 | |
457 | Ubiquitination | AEMEAQLSQALEELG HHHHHHHHHHHHHCC | 11.00 | 24816145 | |
457 | Phosphorylation | AEMEAQLSQALEELG HHHHHHHHHHHHHCC | 11.00 | 23532336 | |
459 | Ubiquitination | MEAQLSQALEELGGQ HHHHHHHHHHHCCCH | 17.36 | 23000965 | |
462 | Ubiquitination | QLSQALEELGGQKQR HHHHHHHHCCCHHHH | 54.27 | 23000965 | |
467 | Ubiquitination | LEELGGQKQRADMLE HHHCCCHHHHHHHHH | 45.05 | 29967540 | |
470 | Ubiquitination | LGGQKQRADMLEMEL CCCHHHHHHHHHHHH | 12.22 | 23000965 | |
478 | Acetylation | DMLEMELKMLKSQSS HHHHHHHHHHHCCCC | 28.96 | 24887495 | |
478 | Ubiquitination | DMLEMELKMLKSQSS HHHHHHHHHHHCCCC | 28.96 | 23000965 | |
481 | Ubiquitination | EMELKMLKSQSSSAE HHHHHHHHCCCCCHH | 42.84 | 23000965 | |
482 | Phosphorylation | MELKMLKSQSSSAEQ HHHHHHHCCCCCHHH | 31.19 | 20068231 | |
484 | Phosphorylation | LKMLKSQSSSAEQSF HHHHHCCCCCHHHHH | 33.09 | 20068231 | |
485 | Phosphorylation | KMLKSQSSSAEQSFL HHHHCCCCCHHHHHH | 26.40 | 20068231 | |
485 | Ubiquitination | KMLKSQSSSAEQSFL HHHHCCCCCHHHHHH | 26.40 | 24816145 | |
486 | Phosphorylation | MLKSQSSSAEQSFLF HHHCCCCCHHHHHHH | 40.86 | 20068231 | |
490 | Phosphorylation | QSSSAEQSFLFSREE CCCCHHHHHHHCHHH | 18.54 | 19691289 | |
494 | Phosphorylation | AEQSFLFSREEADTL HHHHHHHCHHHHHHH | 40.71 | 19691289 | |
500 | Phosphorylation | FSREEADTLRLKVEE HCHHHHHHHHHHHHH | 22.33 | - | |
504 | Ubiquitination | EADTLRLKVEELEGE HHHHHHHHHHHHHCH | 40.96 | 24816145 | |
507 | Ubiquitination | TLRLKVEELEGERSR HHHHHHHHHHCHHHH | 55.92 | 29967540 | |
507 | Ubiquitination | TLRLKVEELEGERSR HHHHHHHHHHCHHHH | 55.92 | - | |
513 | Phosphorylation | EELEGERSRLEEEKR HHHHCHHHHHHHHHH | 36.59 | 22496350 | |
522 | Ubiquitination | LEEEKRMLEAQLERR HHHHHHHHHHHHHHH | 5.99 | 29967540 | |
522 | Ubiquitination | LEEEKRMLEAQLERR HHHHHHHHHHHHHHH | 5.99 | - | |
527 | Ubiquitination | RMLEAQLERRALQGD HHHHHHHHHHHHCCC | 28.21 | 29967540 | |
533 | Ubiquitination | LERRALQGDYDQSRT HHHHHHCCCCCCCCC | 35.97 | 21890473 | |
533 | Ubiquitination | LERRALQGDYDQSRT HHHHHHCCCCCCCCC | 35.97 | 21890473 | |
535 | Phosphorylation | RRALQGDYDQSRTKV HHHHCCCCCCCCCEE | 23.78 | 27642862 | |
538 | Phosphorylation | LQGDYDQSRTKVLHM HCCCCCCCCCEEEEE | 38.73 | 21815630 | |
542 | Ubiquitination | YDQSRTKVLHMSLNP CCCCCCEEEEEECCH | 4.36 | 23000965 | |
545 | Ubiquitination | SRTKVLHMSLNPTSV CCCEEEEEECCHHHH | 4.22 | 23000965 | |
546 | Phosphorylation | RTKVLHMSLNPTSVA CCEEEEEECCHHHHH | 17.78 | 20068231 | |
550 | Phosphorylation | LHMSLNPTSVARQRL EEEECCHHHHHHHHH | 34.46 | 20068231 | |
551 | Phosphorylation | HMSLNPTSVARQRLR EEECCHHHHHHHHHH | 18.29 | 20068231 | |
562 | Phosphorylation | QRLREDHSQLQAECE HHHHHCHHHHHHHHH | 44.93 | 28555341 | |
568 | Ubiquitination | HSQLQAECERLRGLL HHHHHHHHHHHHHHH | 4.06 | 24816145 | |
578 | Ubiquitination | LRGLLRAMERGGTVP HHHHHHHHHHCCCCC | 2.66 | 21890473 | |
583 | Phosphorylation | RAMERGGTVPADLEA HHHHHCCCCCCCHHH | 26.58 | 20068231 | |
594 | Phosphorylation | DLEAAAASLPSSKEV CHHHHHHCCCCHHHH | 35.77 | 20068231 | |
597 | Phosphorylation | AAAASLPSSKEVAEL HHHHCCCCHHHHHHH | 60.37 | 20068231 | |
598 | Phosphorylation | AAASLPSSKEVAELK HHHCCCCHHHHHHHH | 30.78 | 20068231 | |
599 | Ubiquitination | AASLPSSKEVAELKK HHCCCCHHHHHHHHH | 61.62 | 29967540 | |
606 | Ubiquitination | KEVAELKKQVESAEL HHHHHHHHHHHHHHH | 72.67 | 21890473 | |
610 | Phosphorylation | ELKKQVESAELKNQR HHHHHHHHHHHHHHH | 28.34 | 29162720 | |
614 | Ubiquitination | QVESAELKNQRLKEV HHHHHHHHHHHHHHH | 42.41 | 29967540 | |
614 | Acetylation | QVESAELKNQRLKEV HHHHHHHHHHHHHHH | 42.41 | 25953088 | |
619 | Ubiquitination | ELKNQRLKEVFQTKI HHHHHHHHHHHHHHH | 54.76 | 29967540 | |
619 | Malonylation | ELKNQRLKEVFQTKI HHHHHHHHHHHHHHH | 54.76 | 26320211 | |
624 | Phosphorylation | RLKEVFQTKIQEFRK HHHHHHHHHHHHHHH | 20.74 | - | |
625 | Ubiquitination | LKEVFQTKIQEFRKA HHHHHHHHHHHHHHH | 31.44 | 22817900 | |
625 | Acetylation | LKEVFQTKIQEFRKA HHHHHHHHHHHHHHH | 31.44 | 25953088 | |
634 | Phosphorylation | QEFRKACYTLTGYQI HHHHHHHHHHCCCEE | 15.05 | 29162720 | |
649 | Phosphorylation | DITTENQYRLTSLYA EEECCCCEEEEEEEC | 21.12 | 18083107 | |
666 | Acetylation | PGDCLIFKATSPSGS CCCEEEEEEECCCCC | 43.70 | 26051181 | |
680 | Phosphorylation | SKMQLLETEFSHTVG CHHHHEHHHHHCHHH | 42.15 | 18922800 | |
689 | Ubiquitination | FSHTVGELIEVHLRR HHCHHHHHHHHHHCC | 3.13 | 21890473 | |
699 | Phosphorylation | VHLRRQDSIPAFLSS HHHCCCCCHHHHHHH | 23.33 | 18922800 | |
708 | Phosphorylation | PAFLSSLTLELFSRQ HHHHHHHHHHHHHHC | 21.82 | 18922800 | |
713 | Phosphorylation | SLTLELFSRQTVA-- HHHHHHHHHCCCC-- | 35.78 | 20068231 | |
716 | Phosphorylation | LELFSRQTVA----- HHHHHHCCCC----- | 19.79 | 29162720 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
8 | T | Phosphorylation | Kinase | TTK | P33981 | PSP |
22 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
22 | S | Phosphorylation | Kinase | TTK | P33981 | PSP |
29 | S | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
62 | S | Phosphorylation | Kinase | TTK | P33981 | PSP |
214 | S | Phosphorylation | Kinase | ATM | Q13315 | PSP |
323 | T | Phosphorylation | Kinase | TTK | P33981 | PSP |
598 | S | Phosphorylation | Kinase | TTK | P33981 | PSP |
610 | S | Phosphorylation | Kinase | TTK | P33981 | PSP |
624 | T | Phosphorylation | Kinase | TTK | P33981 | PSP |
680 | T | Phosphorylation | Kinase | PLK1 | P53350 | PSP |
716 | T | Phosphorylation | Kinase | TTK | P33981 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | BIRC2 | Q13490 | PMID:18082613 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MD1L1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MD1L1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-61, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-16 AND SER-428, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND MASSSPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-214, AND MASSSPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND MASSSPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, AND MASSSPECTROMETRY. |